HIPEC Cytoreduction/Hyperthermic Intraperitoneal Chemoperfusion is the process of directly applying chemotherapy agents to abdominal cancers. Roswell Park has been utilizing HIPEC for about ten years with promising outcomes. John Kane III, MD, Chief of the Melanoma/Sarcoma Service, and Joseph Skitzki, MD, Assistant Professor of Surgical Oncology and Associate Member of the Department of Immunology, visited Roswellness Radio last Sunday to describe HIPEC in greater detail, how it works, and which patients may be eligible.
Archive - January 2013
Thursday, January 31, 2013 - 3:36pm